FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to chemical-pharmaceutical industry, and concerns a solid individual dosage forms exhibiting antistress, moderate tranquilising, nootropic, antiamnestic and antihypoxic action, containing as an active ingredient, an effective amount of 2-ethyl-6-methyl-3-pyridin-3-ole hydrochloride and pharmaceutically acceptable excipients, which contains 65.0-92.5 wt % of 2-ethyl-6-methyl-pyridin-3-ole hydrochloride, 25.6-2.5 wt % twice-substituted calcium phosphate as an excipient, 0.4-1.9 wt % of oxypropylcellulose as a binding agent and 9.0-0.6 wt % of flowing and anti-adhesion substances. Said dosage form may be presented in the form of a optionally coated marked tablet.
EFFECT: invention provides a method for making said solid individual dosage form, has high bioavailability and shelf life to 5 years.
3 cl, 9 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
COMPOSITION AND METHOD FOR PRODUCING A SOLID DOSAGE FORM CONTAINING (Z)-3-(2-OXO-2-(4-TOLYL)ETHYLIDENE)PIPERAZIN-2-ONE | 2017 |
|
RU2657526C1 |
PHARMACEUTICAL FORMULATION IN SOLID DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2445091C1 |
AFOBASOL-BASE PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2289403C2 |
PHARMACEUTICAL ANTIFUNGAL COMPOSITION BASED ON A CHLOROPHENYLBUTANEDIONE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2707286C1 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC ACTION | 2009 |
|
RU2420304C2 |
"NOOPEPT"-BASE PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2289422C2 |
METHOD FOR PREPARING MEDICINAL AGENT CONTAINING VARDENAFIL HYDROCHLORIDE TRIHYDRATE | 2008 |
|
RU2493849C2 |
PHARMACEUTICAL COMPOSITION WITH ANTIMIGRAINE ACTION (VERSIONS) | 2008 |
|
RU2424803C2 |
Authors
Dates
2012-04-27—Published
2010-10-05—Filed